These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 5040650)

  • 1. An x-ray crystallographic study of the binding of peptide chloromethyl ketone inhibitors to subtilisin BPN'.
    Robertus JD; Alden RA; Birktoft JJ; Kraut J; Powers JC; Wilcox PE
    Biochemistry; 1972 Jun; 11(13):2439-49. PubMed ID: 5040650
    [No Abstract]   [Full Text] [Related]  

  • 2. The aromatic substrate binding site in subtilisin BPN' and its resemblance to chymotrypsin.
    Kraut J; Robertus JD; Birktoft JJ; Alden RA; Wilcox PE; Powers JC
    Cold Spring Harb Symp Quant Biol; 1972; 36():117-23. PubMed ID: 4508128
    [No Abstract]   [Full Text] [Related]  

  • 3. Peptide chloromethyl ketones as irreversible inhibitors of elastase.
    Thompson RC; Blout ER
    Biochemistry; 1973 Jan; 12(1):44-7. PubMed ID: 4734223
    [No Abstract]   [Full Text] [Related]  

  • 4. A kinetic investigation of the crystallographically deduced binding subsites of bovine chymotrypsin A .
    Segal DM
    Biochemistry; 1972 Feb; 11(3):349-56. PubMed ID: 5062058
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibition of subtilisin BPN' with peptide chloromethyl ketones.
    Powers JC; Lively MO; Tippett JT
    Biochim Biophys Acta; 1977 Jan; 480(1):246-61. PubMed ID: 831835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substrate binding site in bovine chymotrypsin A-gamma. A crystallographic study using peptide chloromethyl ketones as site-specific inhibitors.
    Segal DM; Powers JC; Cohen GH; Davies DR; Wilcox PE
    Biochemistry; 1971 Sep; 10(20):3728-38. PubMed ID: 5107010
    [No Abstract]   [Full Text] [Related]  

  • 7. Subtilisin BPN': inactivation by chloromethyl ketone derivates of peptide substrates.
    Morihara K; Oka T
    Arch Biochem Biophys; 1970 Jun; 138(2):526-31. PubMed ID: 5433587
    [No Abstract]   [Full Text] [Related]  

  • 8. The reactivity of His-57 in chymotrypsin to alkylation.
    Shaw E; Ruscica J
    Arch Biochem Biophys; 1971 Aug; 145(2):484-9. PubMed ID: 5132101
    [No Abstract]   [Full Text] [Related]  

  • 9. Subtilisin; a stereochemical mechanism involving transition-state stabilization.
    Robertus JD; Kraut J; Alden RA; Birktoft JJ
    Biochemistry; 1972 Nov; 11(23):4293-303. PubMed ID: 5079900
    [No Abstract]   [Full Text] [Related]  

  • 10. Crystal structure of a subtilisin BPN' complex with N-benzoyl-L-arginine.
    Wright CS; Alden RA; Kraut J
    J Mol Biol; 1972 May; 66(2):283-9. PubMed ID: 5038454
    [No Abstract]   [Full Text] [Related]  

  • 11. The topographical differences in the active site region of alpha-chymotrypsin, subtilisin Novo, and subtilisin Carlsberg. Mapping the aromatic binding site by inhibitors (virtual substrates).
    Bosshard HR; Berger A
    Biochemistry; 1974 Jan; 13(2):266-77. PubMed ID: 4810052
    [No Abstract]   [Full Text] [Related]  

  • 12. A new substrate and two inhibitors applicable for thermitase, subtilisin BPN' and alpha-chymotrypsin. Comparison of kinetic parameters with customary substrates and inhibitors.
    Brömme D; Fittkau S
    Biomed Biochim Acta; 1985; 44(7-8):1089-94. PubMed ID: 3910035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. -Chymotrypsin: what can we learn about catalysis from x-ray diffraction?
    Henderson R; Wright CS; Hess GP; Blow DM
    Cold Spring Harb Symp Quant Biol; 1972; 36():63-70. PubMed ID: 4508173
    [No Abstract]   [Full Text] [Related]  

  • 14. Subtilisin Amylosacchariticus. I. Physicochemical characterization.
    Markland FS; Brown DM; Smith EL
    J Biol Chem; 1972 Sep; 247(17):5596-601. PubMed ID: 5055783
    [No Abstract]   [Full Text] [Related]  

  • 15. The interaction of a tyrosyl residue and carboxyl groups in the specific interaction between Streptomyces subtilisin inhibitor and subtilisin BPN'. A chemical modification study.
    Inouye K; Tonomura B; Hiromi K
    J Biochem; 1979 May; 85(5):1115-26. PubMed ID: 447612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the active site of clostripain. The specific inactivation by the chloromethyl ketone derived from -N-tosyl-L-lysine.
    Porter WH; Cunningham LW; Mitchell WM
    J Biol Chem; 1971 Dec; 246(24):7675-82. PubMed ID: 4332560
    [No Abstract]   [Full Text] [Related]  

  • 17. A chemical and crystallographic study of carbamyl-chymotrypsin A.
    Robillard GT; Powers JC; Wilcox PE
    Biochemistry; 1972 May; 11(10):1773-84. PubMed ID: 5063532
    [No Abstract]   [Full Text] [Related]  

  • 18. Subtilisin BPN': kinetic study with oligopeptides.
    Morihara K; Oka T; Tsuzuki H
    Arch Biochem Biophys; 1970 Jun; 138(2):515-25. PubMed ID: 5433586
    [No Abstract]   [Full Text] [Related]  

  • 19. Active-site geometry of proteinase K. Crystallographic study of its complex with a dipeptide chloromethyl ketone inhibitor.
    Betzel C; Pal GP; Struck M; Jany KD; Saenger W
    FEBS Lett; 1986 Mar; 197(1-2):105-10. PubMed ID: 3512298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of carboxypeptidase Y by chloromethyl ketone derivatives of benzyloxycarbonyl-L-phenylalanine.
    Hayashi R; Bai Y; Hata T
    J Biochem; 1974 Dec; 76(6):1355-7. PubMed ID: 4457553
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.